Trends in Facial Plastic and Reconstructive Surgery

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine".

Deadline for manuscript submissions: 25 September 2024 | Viewed by 1578

Special Issue Editors


E-Mail Website
Guest Editor
Center for Orthognathic and Facial Plastic Surgery, Craniologicum, Bern, Switzerland
Interests: craniomaxillofacial surgery; oral cancer; facial plastic reconstructive surgery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Division of Plastic Surgery, Department of Surgery, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, USA
Interests: plastic and reconstructive surgery

Special Issue Information

Dear Colleagues,

This Special Issue focuses on the evolving trends in facial plastic and reconstructive surgery in 2023. One primary trend is the increasing use of minimally invasive techniques such as fillers and Botox, driven by a preference for less recovery time and natural results. Moreover, the 'Zoom Dysmorphia' phenomenon has amplified demand for facial procedures, particularly around the eyes and jawline. Technological advancements play a significant role, with AI and 3D printing facilitating personalized surgical plans and prosthetics. In reconstructive surgery, regenerative medicine techniques are gaining traction, employing stem cells and growth factors to enhance healing and outcomes. Furthermore, facial gender-affirming surgeries are becoming more commonplace, reflecting societal shifts in understanding gender diversity. However, these advances necessitate a re-evaluation of the importance of a comprehensive patient psychological assessment. This issue thus provides an extensive exploration of the current trends in facial plastic and reconstructive surgery.

Dr. Ali-Farid Safi
Dr. Martin Kauke
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • facial plastic surgery
  • reconstructive surgery
  • regenerative medicine
  • stem cells
  • psychological assessment

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

10 pages, 822 KiB  
Article
Persistent Conjunctival Chemosis after Lower Lid Blepharoplasty: A Comparison of Different Surgical Techniques
by Alessandra Di Maria, Gianmaria Barone, Alessandro Gaeta, Filippo Confalonieri, Paolo Vinciguerra, Valeriano Vinci, Marco Klinger and Vanessa Ferraro
J. Clin. Med. 2024, 13(7), 2093; https://doi.org/10.3390/jcm13072093 - 3 Apr 2024
Viewed by 705
Abstract
Background: Conjunctival chemosis, a complication of lower blepharoplasty, can cause persistent discomfort and functional disturbances with worsening in the postoperative period following surgery. Methods: A review of the records of the lower blepharoplasty procedures carried out at the Humanitas Research Hospital, Rozzano, Milan, [...] Read more.
Background: Conjunctival chemosis, a complication of lower blepharoplasty, can cause persistent discomfort and functional disturbances with worsening in the postoperative period following surgery. Methods: A review of the records of the lower blepharoplasty procedures carried out at the Humanitas Research Hospital, Rozzano, Milan, Italy was performed. Patients were categorized into two groups depending on the procedure performed: (1) transconjunctival blepharoplasty with the removal of the fatty lodges with canthopexy and (2) transcutaneous blepharoplasty with the removal of the fatty lodges with lateral canthoplasty. Each group was further divided into two more groups based on the surgical method used, that is either (a) cold blade and disposable cautery or (b) radiofrequency cut and coagulation and colorado tip (respectively 1a, 1b, 2a and 2b). All patients underwent a postoperative follow-up up to 24 months, which included an evaluation of cosmetic appearance, eyelid scarring and the severity of chemosis. The aim of the study was to investigate which of the surgical procedures causes a lower incidence of persistent type 3 conjunctival chemosis. Results: A total of 1047 patients who underwent lower lid blepharoplasty were included in the study. A total of 512 patients underwent transcutaneous blepharoplasty and 535 underwent the transconjunctival procedure. Among the first group of patients, 266 belong to group 1a and 246 to group 1b. In the second group, 264 were categorized as group 2a and 271 as group 2b. The incidence of type 3 chemosis in the transcutaneous blepharoplasty procedure with lateral canthoplasty was statistically significantly higher than in the transconjunctival approach, considering both the cold blade and the radiofrequency (p = 0.012, 0.010, 0.006, 0.004, respectively). Conclusions: A higher incidence of persistent type 3 conjunctival chemosis is associated with lateral canthus surgery and with the use of radiofrequency. Full article
(This article belongs to the Special Issue Trends in Facial Plastic and Reconstructive Surgery)
Show Figures

Figure 1

Review

Jump to: Research

12 pages, 2162 KiB  
Review
Reconstruction of Craniomaxillofacial Bone Defects with 3D-Printed Bioceramic Implants: Scoping Review and Clinical Case Series
by Maarten Verbist, Anne-Laure Vandevelde, Joris Geusens, Yi Sun, Eman Shaheen and Robin Willaert
J. Clin. Med. 2024, 13(10), 2805; https://doi.org/10.3390/jcm13102805 - 9 May 2024
Viewed by 442
Abstract
Reconstruction of craniomaxillofacial bone defects using 3D-printed hydroxyapatite (HA) bioceramic patient-specific implants (PSIs) is a new technique with great potential. This study aimed to investigate the advantages, disadvantages, and clinical outcomes of these implants in craniomaxillofacial surgeries. The PubMed and Embase databases were [...] Read more.
Reconstruction of craniomaxillofacial bone defects using 3D-printed hydroxyapatite (HA) bioceramic patient-specific implants (PSIs) is a new technique with great potential. This study aimed to investigate the advantages, disadvantages, and clinical outcomes of these implants in craniomaxillofacial surgeries. The PubMed and Embase databases were searched for patients with craniomaxillofacial bone defects treated with bioceramic PSIs. Clinical outcomes such as biocompatibility, biomechanical properties, and aesthetics were evaluated and compared to those of commonly used titanium or poly-ether-ether-ketone (PEEK) implants and autologous bone grafts. Two clinical cases are presented to illustrate the surgical procedure and clinical outcomes of HA bioceramic PSIs. Literature review showed better a biocompatibility of HA PSIs than titanium and PEEK. The initial biomechanical properties were inferior to those of autologous bone grafts, PEEK, and titanium but improved when integrated. Satisfactory aesthetic results were found in our two clinical cases with good stability and absence of bone resorption or infection. Radiological signs of osteogenesis were observed in the two clinical cases six months postoperatively. HA bioceramic PSIs have excellent biocompatible properties and imitate natural bone biomechanically and radiologically. They are a well-suited alternative for conventional biomaterials in the reconstruction of load-sharing bone defects in the craniomaxillofacial region. Full article
(This article belongs to the Special Issue Trends in Facial Plastic and Reconstructive Surgery)
Show Figures

Figure 1

Back to TopTop